Radioligand Therapy (RLT) Market Poised to Reach USD 10.91 Billion by 2035

Radioligand therapy (RLT) is emerging as one of the most promising approaches in precision oncology, offering targeted treatment options for patients with difficult-to-treat cancers. According to rece...